Funding
NIHR300593, Cancer
CANCER
The ASCOT trial is funded by a project grant from the National Institute for Health Research Health Technology Assessment (HTA) programme (HTA 12/35/64). CB’s post is part funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. SC is funded by an NIHR advanced research fellowship (NIHR300593). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.